Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim of the atezobladderpreserve phase II trial (SOGUG-2017-A-IEC(VEJ)-4).May 29, 2024 | ASCO, Comunicaciones a congresos, Pilar Canoa Román, Sergio Vazquez-Estevez
